Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Centrica sells Cygnus field stake to Ithaca Energy for £116m

(Sharecast News) - North Sea operator Ithaca Energy on Tuesday said it had bought an additional 46.25% stake in the Cygnus gas field from Centrica's Spirit Energy in a £116m deal. The move will lift Ithaca's operated interest in Cygnus, located in the Southern North Sea, about 150km east of the Lincolnshire coast, to 85%.

Cygnus was currently producing from 11 wells, with three further infill wells approved, Ithaca said in a statement. It is the largest UK Continental Shelf gas field.

"The transaction is strongly aligned with Centrica and Spirit Energy's strategy to maximise value from Spirit's remaining reserves, delivering attractive upfront cash consideration, and provides further value by transferring long-term liabilities," Centrica said in a separate statement.

"As an existing shareholder and the operator of Cygnus, Ithaca Energy is ideally positioned to take on majority ownership of the asset. Following completion of the transaction, Spirit Energy will remain focused on the development of the long-term Morecambe Net Zero carbon storage project, its remaining producing assets and safely and efficiently decommissioning its facilities and wells with minimum environmental impact."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.